These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16995775)
1. Update on tissue-engineered biological dressings. Ehrenreich M; Ruszczak Z Tissue Eng; 2006 Sep; 12(9):2407-24. PubMed ID: 16995775 [TBL] [Abstract][Full Text] [Related]
2. Update on dermal substitutes. Ehrenreich M; Ruszczak Z Acta Dermatovenerol Croat; 2006; 14(3):172-87. PubMed ID: 17010268 [TBL] [Abstract][Full Text] [Related]
3. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. Langer A; Rogowski W BMC Health Serv Res; 2009 Jul; 9():115. PubMed ID: 19591680 [TBL] [Abstract][Full Text] [Related]
4. Current Available Cellular and Tissue-Based Products for Treatment of Skin Defects. Liu Y; Panayi AC; Bayer LR; Orgill DP Adv Skin Wound Care; 2019 Jan; 32(1):19-25. PubMed ID: 30570555 [TBL] [Abstract][Full Text] [Related]
7. Biologic dressings: current applications and limitations in dermatologic surgery. Chern PL; Baum CL; Arpey CJ Dermatol Surg; 2009 Jun; 35(6):891-906. PubMed ID: 19397669 [TBL] [Abstract][Full Text] [Related]
8. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097 [TBL] [Abstract][Full Text] [Related]
9. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Zaulyanov L; Kirsner RS Clin Interv Aging; 2007; 2(1):93-8. PubMed ID: 18044080 [TBL] [Abstract][Full Text] [Related]
12. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Trent JF; Kirsner RS Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378 [TBL] [Abstract][Full Text] [Related]
13. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers. Karr J Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250 [TBL] [Abstract][Full Text] [Related]
14. The use of Apligraf in acute wounds. Kirsner RS J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773 [TBL] [Abstract][Full Text] [Related]
15. Wound-healing protocols for diabetic foot and pressure ulcers. Brem H; Jacobs T; Vileikyte L; Weinberger S; Gibber M; Gill K; Tarnovskaya A; Entero H; Boulton AJ Surg Technol Int; 2003; 11():85-92. PubMed ID: 12931288 [TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. O'Meara S; Cullum N; Majid M; Sheldon T Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391 [TBL] [Abstract][Full Text] [Related]
17. A rapid fabricated living dermal equivalent for skin tissue engineering: an in vivo evaluation in an acute wound model. Ananta M; Brown RA; Mudera V Tissue Eng Part A; 2012 Feb; 18(3-4):353-61. PubMed ID: 21913837 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279 [TBL] [Abstract][Full Text] [Related]
19. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Macri L; Clark RA Skin Pharmacol Physiol; 2009; 22(2):83-93. PubMed ID: 19188756 [TBL] [Abstract][Full Text] [Related]
20. Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Kopp J; Jeschke MG; Bach AD; Kneser U; Horch RE Cell Tissue Bank; 2004; 5(2):89-96. PubMed ID: 15241004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]